J.&J. Pauses Production of Its Covid Vaccine Despite Persistent Need - The New York Times
A crucial Johnson & Johnson plant has stopped making its Covid vaccine, though the company says it has millions of doses in inventory.
He said the company was continuing to deliver batches of the vaccine to facilities that bottled and packaged doses. He also said Johnson & Johnson had millions of finished doses in inventory.
Jo… [+1802 chars]
Read More
Other Stories in Business
- ACP September 2024 Update: Back In The Green
- Japanese Government Bonds Rise as Bank of Japan Signals Caution on Rate Hikes
- Anwar’s leadership sincerely addressing long-standing issues for Indian community - Xavier
- Welfare of vulnerable groups continues to be given attention - PM Anwar
- » Alternatives to a consumer economy and the point of humanity Early Retirement Extreme: — a combination of simple living, anticonsumerism, DIY ethics, self-reliance, resilience, and applied capitalis
- India IPO Frenzy Calls For Robust Foreign Flows To Avert Jitters In Listed Stocks
- India’s Bond Yields Could Fall To 6.5% Amid Global Rate Trends, Economists Predict
- bajaj finnace shares: Golden Crossovers: These 3 stocks signal further bullishness on September 26 - Bullish Signs
- Piramal Pharma stocks: Add Piramal Pharma, target price Rs 245: ICICI Securities
